Results 231 to 240 of about 6,017,664 (249)
Some of the next articles are maybe not open access.
Drugs of Today, 1998
Zolmitriptan, a selective 5-HT(1B/D) agonist was developed for the acute treatment of migraine. Dose-finding studies show a clearly defined dose response curve for the oral formulation with onset of efficacy demonstrated within 45 min of dosing. Clinical trials support its efficacy in all types of migraine, with excellent safety and tolerability in ...
openaire +2 more sources
Zolmitriptan, a selective 5-HT(1B/D) agonist was developed for the acute treatment of migraine. Dose-finding studies show a clearly defined dose response curve for the oral formulation with onset of efficacy demonstrated within 45 min of dosing. Clinical trials support its efficacy in all types of migraine, with excellent safety and tolerability in ...
openaire +2 more sources
Psychopathology, 2010
This literature review addresses two related questions: Is buspirone as clinically effective an antianxiety agent as the benzodiazepines ? And does buspirone offer any safety advantages? Data from over 1,000 anxious outpatients reveal that an average dose of 20 mg of buspirone/day appears to be as effective an antianxiety agent as comparable doses of ...
openaire +2 more sources
This literature review addresses two related questions: Is buspirone as clinically effective an antianxiety agent as the benzodiazepines ? And does buspirone offer any safety advantages? Data from over 1,000 anxious outpatients reveal that an average dose of 20 mg of buspirone/day appears to be as effective an antianxiety agent as comparable doses of ...
openaire +2 more sources
CLINICAL STUDIES ON TERRAMYCIN
Annals of the New York Academy of Sciences, 1950M, FINLAND +4 more
openaire +2 more sources
Clinical studies of topiramate
Drugs of Today, 1999Topiramate had well-documented efficacy as an adjunctive agent for partial-onset seizures in 5 double-blind, parallel trials, reducing seizure frequency by 35-47% at 400 mg/day, the optimal dose for most patients. It can also be used as monotherapy for partial-onset seizures. A broad spectrum of action is suggested by studies showing efficacy against a
openaire +2 more sources
CLINICAL STUDIES WITH AUREOMYCIN
Annals of the New York Academy of Sciences, 1948H S, COLLINS, T F, PAINE, M, FINLAND
openaire +2 more sources
A Clinical Study of Cephalexin
The Journal of Clinical Pharmacology and New Drugs, 1973openaire +2 more sources
Clinical Studies with Cephalothin
Journal of Urology, 1966F M, Wilson, J W, Retan, A M, Lerner
openaire +2 more sources